AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Emergent BioSolutions Inc. Director's Dealing 2023

Oct 6, 2023

32870_dirs_2023-10-05_ee229daf-7693-431d-9091-e979d1d58524.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2023-10-01

Reporting Person: DeGolyer Donald W (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct